TOPICAL IMMUNOTROPIC AGENTS IN TREATMENT
Abstract
Of intercurrent infections in children with allergic pathology use of topical bacterial lyzates as a therapy for intercurrent infections in children with allergic pathology is reviewed basing on publications and personal clinical experience. Deficient mucous immunity has been established in allergic children with recurrent and acute upper respiratory tract and herpes virus infections, thus providing base for use of immunomodulators as a part of complex treatment for this group of patients.
Key words: children, allergic diseases, respiratory tract infections, stomatitis, prophylaxis, treatment, immunomodulators.
About the Authors
V.A. Bulgakova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
I.I. Balabolkin
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
T.B. Sentsova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
L.K. Katosova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
I.V. Ryleeva
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
N.V. Yukhtina
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
N.V. Bashilova
Научный центр здоровья детей РАМН, Москва
Russian Federation
For citations:
Bulgakova V.,
Balabolkin I.,
Sentsova T.,
Katosova L.,
Ryleeva I.,
Yukhtina N.,
Bashilova N.
TOPICAL IMMUNOTROPIC AGENTS IN TREATMENT. Pediatric pharmacology. 2006;3(4):56-62.
Views:
498